Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Feature

Jay-Z and Scarface: pharma staff’s anonymous Wikipedia interests

Jay-Z and Scarface: pharma staff’s anonymous Wikipedia interests

Big pharma employees are among the brightest minds in the world, and data released yesterday on their Wikipedia use shows their interests spread beyond drug development into lighter fare.

Related news

News in brief

Drugmakers are bringing sterile injectables capacity back in-house according to a Frost & Sullivan analyst, who says industry risk aversion is the key driver.

Botox maker Allergan announced sales and earnings per share growth above the high end of its expectations, but it will cut 1,500 jobs, or about 13% of its workforce as it continues to avoid a $54bn hostile takeover bid from Valeant Pharmaceuticals.

Scientists in Sweden have developed a magnesium carbonate-based excipient they claim is a low-cost nanotech alternative to silica for drugmakers struggling to formulate insoluble APIs.

PhRMA (Pharmaceutical Research and Manufacturers of America) has warned that illegal medicines rejected at the US border will continue to be resubmitted for importation unless a proposed law allows their destruction.

Global Industry News

Pamplona CMO bullish about biopharma prospects after fundraising from BioPharma-Reporter.com

3P Biopharmaceuticals has raised funds and announced plans to invest in its manufacturing capabilities to meet the needs of international clients.

News in brief

Mymetics to manufacture HER-Vaxx cancer immunotherapy from BioPharma-Reporter.com

Swiss-based Mymetics has agreed with Australian biotech Imugene to manufacture and develop its cancer immunotherapy HER-Vaxx, which is expected to enter into a Phase I/II clinical trial in 2015.

News in brief

Quintiles to commercialize antibiotic in Europe from Outsourcing-Pharma.com

Basilea Pharmaceutica has selected Quintiles to commercialize its antibiotic Zevtera/Mabelio (ceftobiprole medocaril) in Europe.

CRO SynteractHCR recognized by Swiss for clinical training program from Outsourcing-Pharma.com

A Swiss association has recognized the European Centre for Clinical Research Training (ECCRT), a SynteractHCR company, for training investigators and sub-investigators on GCP (good clinical practice).  

Big Pharma's 'intellectual arrogance' stunts CMO partnerships, says GPCM Chair from Outsourcing-Pharma.com

Efficient relationships with contract manufacturers are being held back by Big Pharma’s ‘intellectual arrogance’ and ill-defined operational teams, according to an ex-Director at GlaxoSmithKline.

Spotlight

Exporters rush to meet Chinese FDA serialisation requirements

Exporters rush to meet Chinese FDA serialisation requirements

Pharmaceutical companies are rushing to respond to shortened deadlines from China’s Food and Drug Administration (CFDA) for...

GSK confident despite endotoxin problems at Canadian vaccine plant

GSK confident despite ongoing endotoxin problems at Canadian flu vaccine plant

GSK is confident it can meet Flulaval production targets ahead of this winter’s flu season despite ongoing...

Marketing agency targets poor interns for GSK paid trials

Marketing agency targets poor interns for GSK paid trials

Representatives for GSK have targeted struggling graduates and unpaid interns as volunteers for clinical trials, saying the...

Roche: ‘If suppliers don’t open up their books, then we are done’

Roche: ‘If suppliers don’t open up their books, then we are done’

Drug raw materials suppliers have not recognised their potential value to biopharmaceutical customers according to Roche which...

Teva's 70+ manufacturing sites could be halved in efficiency drive

Teva's 70+ manufacturing sites could be halved in efficiency drive

Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh,...

Key Industry Events

 

Access all events listing

Our events, Events from partners...